SCHEMBL12796147

SCHEMBL12796147

Nc1ccccc1Cn1ncc2cnc(Nc3ccon3)nc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 8/20 0.42
ADORA1 P30542 8/20 0.42
IGF1R P08069 2/20 0.36
ULK1 O75385 1/20 0.35
ADORA3 P0DMS8 1/20 0.34
ADORA2B P29275 1/20 0.34
STAT6 P42226 1/20 0.34
JAK3 P52333 1/20 0.33
GUCY1B2 O75343 2/20 0.33
GUCY1A2 P33402 2/20 0.33
GUCY1A1 Q02108 2/20 0.33
GUCY1B1 Q02153 2/20 0.33
PIK3CD O00329 1/20 0.32
PIK3CA P42336 1/20 0.32
PIK3CB P42338 1/20 0.32
MTOR P42345 1/20 0.32
PIK3CG P48736 1/20 0.32
OPRK1 P41145 1/20 0.32
YTHDC1 Q96MU7 1/20 0.31
CDK1 P06493 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1662480 0.85 NPBWR1 (0.37) IGF1RULK1JAK3GUCY1B2GUCY1A2
SCHEMBL12797021 0.81 ADORA2A (0.40) ADORA2AADORA1ADORA3ADORA2BSTAT6
SCHEMBL12797295 0.80 FLT4 (0.41) ADORA2AADORA1IGF1RJAK3PTK2
SCHEMBL12797025 0.78 IGF1R (0.42) ADORA2AADORA1IGF1RJAK3CCNE1
SCHEMBL12797024 0.78 IGF1R (0.42) ADORA2AADORA1IGF1RJAK3CCNE1
SCHEMBL12796992 0.77 JAK3 (0.47) JAK3CDK2
SCHEMBL12796158 0.77 FLT4 (0.40) ADORA2AADORA1STAT6JAK3PIK3CD
SCHEMBL12795250 0.76 MAPK1 (0.44) ADORA2AADORA1JAK3CDK2PTK2
SCHEMBL12796169 0.75 EIF2AK4 (0.52) JAK3
SCHEMBL12797296 0.74 JAK3 (0.47) JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011048082-A1 HETEROCYCLYL PYRAZOLOPYRIMIDINE ANALOGUES AS JAK INHIBITORS CELLZOME LIMITED (GB) 2011-04-28 WO disclosed